Juan Jesús
Gómez-Reino Carnota
Helsinki University Central Hospital
Helsinki, FinlandiaPublicacións en colaboración con investigadores/as de Helsinki University Central Hospital (7)
2022
-
After JAK inhibitor failure: To cycle or to switch, that is the question - Data from the JAK-pot collaboration of registries
Annals of the Rheumatic Diseases, Vol. 82, Núm. 2, pp. 175-181
2019
-
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1536-1544
2017
-
Rituximab retreatment in rheumatoid arthritis in a real-life cohort: Data from the CERERRA collaboration
Journal of Rheumatology, Vol. 44, Núm. 2, pp. 162-169
2016
-
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration
Arthritis Research and Therapy, Vol. 18, Núm. 1
-
Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration [Arthritis Res Ther. 18: (2016); 50], doi: 10.1186/s13075-016-0951-z
Arthritis Research and Therapy
2012
-
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: Results of a 1-year follow-up study from the CERERRA collaboration
Annals of the Rheumatic Diseases, Vol. 71, Núm. 3, pp. 374-377
2011
-
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: Pooled data from 10 European registries
Annals of the Rheumatic Diseases, Vol. 70, Núm. 9, pp. 1575-1580